
Overview
PSMA PET (Positron Emission Tomography) Scan: This imaging test uses a radioactive tracer that binds to PSMA. The scan can detect prostate cancer cells throughout the body, including small tumors that may have been missed by other imaging methods.
Datasets include: Confirmed Prostate cancer with pharmaceuticals 68Ga-PSMA11 or 18F-DCFPyL, or 18F-rhPSMA7.3. PSMA PET CT with 10% of cases with liver lesions, 10% of cases with lung lesions, 5% cases with adrenal gland metastases.
in the Datasets
- 600 studies
Inclusion / Exclusion Criteria Pharmaceutical: 68Ga-PSMA11, or 18F-rhPSMA7.3 Liver mets Lung mets Adrenal Gland mets All mets as well All scanning vendors Ages 18-89 All race and ethnicity included
Details
Introducing multi-product solutions
You can now purchase comprehensive solutions tailored to use cases and industries.
Features and programs
Financing for AWS Marketplace purchases
Pricing
Vendor refund policy
Refunds are not offered for this product.
How can we make this page better?
Legal
Vendor terms and conditions
Content disclaimer
Delivery details
AWS Data Exchange (ADX)
AWS Data Exchange is a service that helps AWS easily share and manage data entitlements from other organizations at scale.
Additional details
You will receive access to the following data sets.
Data set name | Type | Historical revisions | Future revisions | Sensitive information | Data dictionaries | Data samples |
|---|---|---|---|---|---|---|
Prostate Cancer - PSMA-PET_PROSTATE | All historical revisions | All future revisions | Not included | Not included |
Resources
Vendor resources
Similar products
